Skip to content
Clinical Trials for Alzheimer's Disease

Philadelphia, Pennsylvania

Alzheimer's disease clinical trials in Philadelphia, PA

10 Alzheimer's disease studies are recruiting participants at sites in Philadelphia as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Philadelphia at a glance

  • 10 studies are recruiting at a site in Philadelphia.
  • By phase: Early Phase 1 (1), Phase 2 (2), Phase 3 (2), No phase (2), Observational (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (7), industry (3).
  • Most recent update to one of these records: November 4, 2026.

Studies recruiting in Philadelphia

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Pennsylvania Hospital
    Registry record
    NCT07589595 · updated
  2. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Celgene
    Study site
    Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience
    Registry record
    NCT06808984 · updated
  3. PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Pennsylvania
    Study site
    Perelman Center for Advance Medicine
    Registry record
    NCT05456503 · updated
  4. Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

    • No phase
    • Ages 70 and older
    • All sexes
    Sponsor
    University of Michigan
    Study site
    Hospital of the University of Pennsylvania
    Registry record
    NCT05929703 · updated
  5. Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

    • Observational
    • Ages 18 to 120
    • All sexes
    Sponsor
    University of Pennsylvania
    Study site
    University of Pennsylvania
    Registry record
    NCT05658913 · updated
  6. Biofluid Research on Age-Related or Inherited Neurodegeneration

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Pennsylvania
    Study site
    University of Pennsylvania
    Registry record
    NCT07798700 · updated
  7. Using the EHR to Advance Genomic Medicine Across a Diverse Health System

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Pennsylvania
    Study site
    Penn Medicine
    Registry record
    NCT06377033 · updated
  8. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study site
    Penn Presbyterian Medical Center
    Registry record
    NCT06563895 · updated
  9. UPenn Observational Research Repository on Neurodegenerative Disease

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Pennsylvania
    Study site
    University of Pennsylvania
    Registry record
    NCT04715399 · updated
  10. Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

    • Early Phase 1
    • Ages 40 to 85
    • All sexes
    Sponsor
    University of Pennsylvania
    Study site
    University of Pennsylvania
    Registry record
    NCT06932809 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Ask about studies near Philadelphia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Pennsylvania

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call